Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal …
RJ Motzer, MD Michaelson, BG Redman… - Journal of Clinical …, 2006 - ascopubs.org
Purpose Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
[引用][C] Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic …
RJ MOTZER, MD MICHAELSON, JZ LI… - Journal of clinical …, 2006 - pascal-francis.inist.fr
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor
and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma …
and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma …
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal …
RJ Motzer, MD Michaelson, BG Redman… - Journal of Clinical …, 2005 - europepmc.org
Purpose Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic …
RJ Motzer, MD Michaelson, BG Redman… - Journal of Clinical …, 2006 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Renal cell carcinoma (RCC) is
characterized by loss of von Hippel Lindau tumor suppressor gene activity, resulting in high …
characterized by loss of von Hippel Lindau tumor suppressor gene activity, resulting in high …
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal …
RJ Motzer, MD Michaelson… - Journal of clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal …
RJ Motzer, MD Michaelson… - Journal of …, 2006 - mdanderson.elsevierpure.com
Purpose: Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
suppressor gene activity, resulting in high expression of pro-angiogenic growth factors …
[引用][C] Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, patients with metastatic …
M RJ - J. Clin. Oncol., 2006 - cir.nii.ac.jp
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and
platelet-derived growth factor receptor, patients with metastatic renal cell carcinoma | CiNii …
platelet-derived growth factor receptor, patients with metastatic renal cell carcinoma | CiNii …